Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Bluejay Diagnostics, Inc. (BJDX : NSDQ)

• Company Description    Bluejay Diagnostics Inc. is a late-stage, pre-revenue medical device company. It focused on developing near-patient products for triage, diagnosis and monitoring of disease progression. Bluejay Diagnostics Inc. is based in ACTON, Mass. Number of Employees: 9

• Price / Volume Information    Yesterday's Closing Price: $1.04 Daily Weekly Monthly 20 Day Moving Average: 201,332 shares Shares Outstanding: 20.15 (millions) Market Capitalization: $21.06 (millions) Beta: 52 Week High: $6.25 52 Week Low: $0.82 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 10.82% 20.93% 12 Week 10.00% 15.81% Year To Date -59.18% -52.42%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 360 MASSACHUSETTS AVENUE SUITE 203 - ACTON,MA 01720 USA ph: 844-327-7078 fax: - ir@bluejaydx.com https://bluejaydx.com

• General Corporate Information    Officers Neil Dey - Chief Executive Officer Douglas C. Wurth - Chairman of the Board of Directors Gordon Kinder - Chief Financial Officer Donald R. Chase - Director Svetlana Dey - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 095633103 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 07/20/22 Share - Related Items Shares Outstanding: 20.15 Most Recent Split Date: (:1) Beta: Market Capitalization: $21.06 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.08 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.32 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 07/20/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.14 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -11.11% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/22 - - 12/31/21 - - 09/30/21 - - ROA 03/31/22 - - 12/31/21 - - 09/30/21 - - Current Ratio 03/31/22 - 14.76 12/31/21 - 32.43 09/30/21 - 0.69 Quick Ratio 03/31/22 - 14.08 12/31/21 - 32.43 09/30/21 - 0.69 Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Book Value 03/31/22 - 0.92 12/31/21 - 1.05 09/30/21 - -0.10 Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - - Debt-to-Capital 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - -

Powered by Zacks Investment Research ©